April 15, 2016
C-Path collaborates with FDA’s CDER and FNIH’s Biomarker Consortium in drafting a “Framework for Defining Evidentiary Criteria for Biomarker Qualification”
C-Path collaborates with FDA’s CDER and FNIH’s Biomarker Consortium in drafting a “Framework for Defining Evidentiary Criteria for Biomarker Qualification”
